Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Sure Winners: 7 Stocks Set to Outperform in the Next Recession
06:45am, Wednesday, 04'th Oct 2023
As economic certainty wanes, investors are looking for stocks to buy for a recession. From the first one's consistent revenue growth to the second one's data-driven success, the third's focus on lower
Market Sell-Off: 5 Stocks I Am Buying Now
05:21am, Wednesday, 04'th Oct 2023
September historically experiences a stock market sell-off, driven by factors like seasonal portfolio rebalancing and investor psychology. Recent market decline presents buying opportunities, with sto
Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna
04:36pm, Tuesday, 03'rd Oct 2023
The Food and Drug Administration signed off on Novavax's updated Covid booster late Tuesday, and NVAX stock surged just before the close.
FDA approves updated Novavax Covid vaccine as Pfizer, Moderna shots roll out in U.S.
02:44pm, Tuesday, 03'rd Oct 2023
Health officials see Novavax's protein-based vaccine as a valuable alternative for people who don't want to take messenger RNA shots from Pfizer and Moderna.
Dividend Paying Stocks To Buy In October 2023? 2 In Focus
10:22am, Tuesday, 03'rd Oct 2023
Dividend paying stocks to check out in the stock market today.
The 3 Top Value Stocks to Watch in Q4 2023
06:00am, Tuesday, 03'rd Oct 2023
Amid the tumult of a turbulent market landscape, savvy investors cast a hopeful eye toward top value stocks. The Dow is down, shedding over 100 points on Friday, and both the S&P 500 and Nasdaq are wr
Is Pfizer Stock a Buy Now?
06:00am, Tuesday, 03'rd Oct 2023
Pfizer's coronavirus product revenue is on the decline, and the company faces a patent cliff. But the big pharma is also launching new products at its fastest pace ever.
3 Massively Undervalued Dividend Stocks to Buy for High Total Returns
03:55pm, Monday, 02'nd Oct 2023
The markets have a reason to cheer in the near-term with the debt ceiling crisis averted. Notably, the last quarter has historically been good for equities.
Drugmakers sign on to negotiate Medicare prices under protest
01:02pm, Monday, 02'nd Oct 2023
All the drugmakers that make the 10 prescription medicines subject to the first-ever price negotiations for the U.S. Medicare health program, including Amgen and Novartis , said they signed on to part
Q4 Stock Predictions: 3 Pharma Stocks Ready to Roar Into 2024
11:32am, Monday, 02'nd Oct 2023
With a few exceptions, pharmaceutical stocks have underperformed the broader market this year. The S&P Pharmaceutical Index is down 3% year to date versus a 12% gain in the benchmark S&P 500.
3 Top Stocks to Buy in October and Hold Forever
09:40am, Monday, 02'nd Oct 2023
UnitedHealth is showing no signs of slowing down. Pfizer's sell-off has gone too far.
Why Pfizer and BioNTech Stocks Zoomed Higher Today
07:03pm, Friday, 29'th Sep 2023
While people in this country aren't rushing in masses to get updated COVID booster vaccines, take-up has been encouraging. Many are worried about an apparent resurgence in the affliction.
Final Trades: Rivian, Pfizer, Treasury Bonds and more
06:26pm, Friday, 29'th Sep 2023
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Goldman Sachs' Chris Shibutani talks his top biotech picks including Eli Lilly and Pfizer
05:43pm, Friday, 29'th Sep 2023
Chris Shibutani, Goldman Sachs Senior Analyst, joins 'Closing Bell Overtime' to talk his top picks in the biotech sectors.
3 Stocks to Focus on as Demand for Obesity Drugs Booms
11:17am, Friday, 29'th Sep 2023
The market for obesity and weight management drugs is attracting a lot of interest lately in the United States. Patients are gradually understanding the benefits of obesity drugs like Novo Nordisk's N
